These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21183509)

  • 21. Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia.
    Ashino T; Yamamoto M; Yoshida T; Numazawa S
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):760-8. PubMed ID: 23413426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BET bromodomain-containing epigenetic reader proteins regulate vascular smooth muscle cell proliferation and neointima formation.
    Dutzmann J; Haertlé M; Daniel JM; Kloss F; Musmann RJ; Kalies K; Knöpp K; Pilowski C; Sirisko M; Sieweke JT; Bauersachs J; Sedding DG; Gegel S
    Cardiovasc Res; 2021 Feb; 117(3):850-862. PubMed ID: 32353113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cysteine-rich protein 2 alters p130Cas localization and inhibits vascular smooth muscle cell migration.
    Chen CH; Ho YC; Ho HH; Chang IC; Kirsch KH; Chuang YJ; Layne MD; Yet SF
    Cardiovasc Res; 2013 Dec; 100(3):461-71. PubMed ID: 23975851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wnt2 and WISP-1/CCN4 Induce Intimal Thickening via Promotion of Smooth Muscle Cell Migration.
    Williams H; Mill CA; Monk BA; Hulin-Curtis S; Johnson JL; George SJ
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1417-24. PubMed ID: 27199447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myocardin regulates vascular smooth muscle cell inflammatory activation and disease.
    Ackers-Johnson M; Talasila A; Sage AP; Long X; Bot I; Morrell NW; Bennett MR; Miano JM; Sinha S
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):817-28. PubMed ID: 25614278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparan sulfate side chains have a critical role in the inhibitory effects of perlecan on vascular smooth muscle cell response to arterial injury.
    Gotha L; Lim SY; Osherov AB; Wolff R; Qiang B; Erlich I; Nili N; Pillarisetti S; Chang YT; Tran PK; Tryggvason K; Hedin U; Tran-Lundmark K; Advani SL; Gilbert RE; Strauss BH
    Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H337-45. PubMed ID: 24858854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptome profiling reveals that the SM22α-regulated molecular pathways contribute to vascular pathology.
    Chen R; Zhang F; Song L; Shu Y; Lin Y; Dong L; Nie X; Zhang D; Chen P; Han M
    J Mol Cell Cardiol; 2014 Jul; 72():263-72. PubMed ID: 24735829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
    Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophage migration inhibitory factor triggers vascular smooth muscle cell dedifferentiation by a p68-serum response factor axis.
    Fan Y; Zhang J; Chen CY; Xiao YB; Asico LD; Jose PA; Xu JC; Qian GS; Zeng CY
    Cardiovasc Res; 2017 Apr; 113(5):519-530. PubMed ID: 28165114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Serum HMGB2 Levels With In-Stent Restenosis: HMGB2 Promotes Neointimal Hyperplasia in Mice With Femoral Artery Injury and Proliferation and Migration of VSMCs.
    He YH; Wang XQ; Zhang J; Liu ZH; Pan WQ; Shen Y; Zhu ZB; Wang LJ; Yan XX; Yang K; Zhang RY; Shen WF; Ding FH; Lu L
    Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):717-729. PubMed ID: 28183701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of FOXO1/3 promotes vascular calcification.
    Deng L; Huang L; Sun Y; Heath JM; Wu H; Chen Y
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):175-83. PubMed ID: 25378413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TRAIL promotes VSMC proliferation and neointima formation in a FGF-2-, Sp1 phosphorylation-, and NFkappaB-dependent manner.
    Chan J; Prado-Lourenco L; Khachigian LM; Bennett MR; Di Bartolo BA; Kavurma MM
    Circ Res; 2010 Apr; 106(6):1061-71. PubMed ID: 20150555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mindin regulates vascular smooth muscle cell phenotype and prevents neointima formation.
    Zhu LH; Huang L; Zhang X; Zhang P; Zhang SM; Guan H; Zhang Y; Zhu XY; Tian S; Deng K; Li H
    Clin Sci (Lond); 2015 Jul; 129(2):129-45. PubMed ID: 25751394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The induction of yes-associated protein expression after arterial injury is crucial for smooth muscle phenotypic modulation and neointima formation.
    Wang X; Hu G; Gao X; Wang Y; Zhang W; Harmon EY; Zhi X; Xu Z; Lennartz MR; Barroso M; Trebak M; Chen C; Zhou J
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2662-9. PubMed ID: 22922963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Na+, HCO3--cotransporter NBCn1 increases pHi gradients, filopodia, and migration of smooth muscle cells and promotes arterial remodelling.
    Boedtkjer E; Bentzon JF; Dam VS; Aalkjaer C
    Cardiovasc Res; 2016 Aug; 111(3):227-39. PubMed ID: 27076468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SGK1 induces vascular smooth muscle cell calcification through NF-κB signaling.
    Voelkl J; Luong TT; Tuffaha R; Musculus K; Auer T; Lian X; Daniel C; Zickler D; Boehme B; Sacherer M; Metzler B; Kuhl D; Gollasch M; Amann K; Müller DN; Pieske B; Lang F; Alesutan I
    J Clin Invest; 2018 Jul; 128(7):3024-3040. PubMed ID: 29889103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation.
    Cheng Y; Liu X; Yang J; Lin Y; Xu DZ; Lu Q; Deitch EA; Huo Y; Delphin ES; Zhang C
    Circ Res; 2009 Jul; 105(2):158-66. PubMed ID: 19542014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Replicative senescence of vascular smooth muscle cells enhances the calcification through initiating the osteoblastic transition.
    Nakano-Kurimoto R; Ikeda K; Uraoka M; Nakagawa Y; Yutaka K; Koide M; Takahashi T; Matoba S; Yamada H; Okigaki M; Matsubara H
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1673-84. PubMed ID: 19749165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of coronin 1B in PDGF-induced migration of vascular smooth muscle cells.
    Williams HC; San Martín A; Adamo CM; Seidel-Rogol B; Pounkova L; Datla SR; Lassègue B; Bear JE; Griendling K
    Circ Res; 2012 Jun; 111(1):56-65. PubMed ID: 22619279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The bone morphogenetic protein antagonist gremlin promotes vascular smooth muscle cell apoptosis.
    Maciel TT; Melo RS; Campos AH
    J Vasc Res; 2009; 46(4):325-32. PubMed ID: 19142012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.